Back to results
US 2008/0167222 A1Published application
Use of Growth Hormone Releasing Factor Analogs in Treating Patients Suffering From Wasting
AssigneeTheratechnologies Inc.
InventorsBruno Lussier, Luc Vachon, Soraya Allas, Thierry Abribat
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for using growth hormone releasing factor analogs of the formula (A), X-GRF Peptide, and pharmaceutically acceptable salts thereof, for increasing muscle function in a subject. Also disclosed herein are corresponding methods, packages and compositions.
Claims40
A method of increasing muscle function in a subject, said method comprising administering to said subject an agent selected from the group consisting of:
- (a) a growth hormone (GH) secretagogue;
- and
- (b) a composition comprising a GH secretagogue and a pharmaceutically acceptable carrier.
25-49. (canceled)
A package comprising:
- (i) an agent selected from the group consisting of:
- (a) a growth hormone (GH) secretagogue;
- and
- (b) a composition comprising a GH secretagogue and a pharmaceutically acceptable carrier;
- and
- (ii) instructions for increasing muscle function in a subject.
3 more elements
57-73. (canceled)
A composition for increasing muscle function in a subject, said composition comprising:
- (a) a growth hormone (GH) secretagogue;
- and
- (b) a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.